STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Emerson Reports Fourth Quarter and Full Year 2025 Results; Provides Initial 2026 Outlook

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Emerson (NYSE: EMR) reported fiscal Q4 and full-year 2025 results for the period ended Sept. 30, 2025, and provided initial 2026 guidance. Q4 net sales were $4,855 million, up 5% year-over-year; FY sales were $18,016 million, up 3% year-over-year. GAAP EPS was $1.12 in Q4 and $4.03 for FY 2025; Adjusted EPS was $1.62 in Q4 and $6.00 for FY 2025. Emerson reported margin expansion (FY adjusted segment EBITA margin to 27.6%) and FY free cash flow of $3,245 million.

The board approved a 5% quarterly dividend increase to $0.555 per share (payable Dec. 10, record Nov. 14) and authorized repurchases of up to 50 million shares, in addition to ~20 million shares remaining from a prior authorization. 2026 guidance: Adjusted EPS $6.35–$6.55, GAAP EPS $4.73–$4.93, operating cash flow $4.0–$4.1B, free cash flow $3.5–$3.6B, and planned cash returns of ~$2.2B (~$1.0B repurchases, ~$1.2B dividends).

Emerson (NYSE: EMR) ha riportato i risultati fiscali del Q4 e dell'intero anno 2025 per il periodo terminato il 30 settembre 2025, e ha fornito una prima guidance per il 2026. Le vendite nette del Q4 sono state di 4.855 milioni di dollari, in aumento del 5% su base annua; le vendite FY sono state di 18.016 milioni, in aumento del 3% su base annua. l'EPS GAAP è stato di 1,12 dollari nel Q4 e 4,03 per l'anno fiscale 2025; l'EPS rettificato è stato di 1,62 nel Q4 e 6,00 per l'anno fiscale 2025. Emerson ha registrato un'espansione della redditività (margine EBITA rettificato per l'anno al 27,6%) e un flusso di cassa libero annuale di 3.245 milioni di dollari.

Il consiglio di amministrazione ha approvato un aumento del dividendo trimestrale del 5% a 0,555 dollari per azione (pagamento 10 dicembre, record 14 novembre) e ha autorizzato riacquisti di fino a 50 milioni di azioni, oltre alle circa 20 milioni di azioni residue dall'autorizzazione precedente. Guida per il 2026: EPS rettificato 6,35–6,55 dollari, EPS GAAP 4,73–4,93, flusso di cassa operativo 4,0–4,1 miliardi, flusso di cassa libero 3,5–3,6 miliardi, e piani di ritorno di capitale di circa 2,2 miliardi di dollari (circa 1,0 miliardo di riacquisti, circa 1,2 miliardi di dividendi).

Emerson (NYSE: EMR) presentó resultados del cuarto trimestre y del año completo 2025 para el periodo terminado el 30 de septiembre de 2025, y proporcionó una guía inicial para 2026. Las ventas netas del Q4 fueron de 4.855 millones de dólares, un aumento del 5% interanual; las ventas del año fiscal fueron de 18.016 millones, un aumento del 3% interanual. EL EPS GAAP fue de 1,12 dólares en el Q4 y 4,03 para el año fiscal 2025; EL EPS ajustado fue de 1,62 en el Q4 y 6,00 para el año fiscal 2025. Emerson reportó expansión de márgenes (margen EBITA ajustado por segmento para el año del 27,6%) y un flujo de caja libre anual de 3.245 millones de dólares.

La junta directiva aprobó un aumento del dividendo trimestral del 5% a 0,555 dólares por acción (pago el 10 de diciembre, registro el 14 de noviembre) y autorizó recompras de hasta 50 millones de acciones, además de las ~20 millones de acciones que quedan de una autorización previa. Guía para 2026: EPS ajustado 6,35–6,55, EPS GAAP 4,73–4,93, flujo de efectivo operativo 4,0–4,1 mil millones, flujo de efectivo libre 3,5–3,6 mil millones, y planes de retornos de efectivo de ~2,2 mil millones (~1,0 mil millones en recompras, ~1,2 mil millones en dividendos).

에머슨(NYSE: EMR)은 2025년 9월 30일로 종료된 기간에 대한 2025 회계연도 4분기(Q4) 및 연간 실적과 2026년 초기 전망을 발표했습니다. Q4 매출은 48억 5,500만 달러로 전년 대비 5% 증가했으며; FY 매출은 180억 1,6천만 달러로 전년 대비 3% 증가했습니다. GAAP EPS는 Q4에서 1.12달러, 2025 회계연도 전체에서 4.03달러였고; 조정된 EPS는 Q4에서 1.62달러, 2025 회계연도 전체에서 6.00달러였습니다. 에머슨은 마진 확장(FY 조정된 부문 EBITA 마진 27.6%)과 연간 자유 현금 흐름 324.5억 달러를 보고했습니다.

이사회는 분기 배당 5% 인상을 주당 0.555달러로 승인했고(12월 10일 지급, 11월 14일 기록), 추가로 최대 5천만 주의 자사주 매입을 승인했습니다. 이전 승인으로 남아 있는 약 2천만 주를 포함합니다. 2026년 가이던스: 조정 EPS 6.35~6.55, GAAP EPS 4.73~4.93, 영업 현금 흐름 40억~41억 달러, 자유 현금 흐름 35억~36억 달러, 현금 배당 및 자본 반환 계획 약 22억 달러(약 10억 달러 자사주 매입, 약 12억 달러 배당).

Emerson (NYSE: EMR) a publié les résultats du T4 et de l'exercice 2025 dans son ensemble pour la période se terminant le 30 septembre 2025 et a fourni une première orientation pour 2026. Les ventes nettes du Q4 se sont élevées à 4 855 millions de dollars, en hausse de 5 % en glissement annuel ; les ventes de l'exercice se sont élevées à 18 016 millions, en hausse de 3 % en glissement annuel. EPS GAAP était de 1,12 $ au Q4 et 4,03 $ pour l'exercice 2025 ; EPS ajusté était de 1,62 $ au Q4 et 6,00 $ pour l'exercice 2025. Emerson a enregistré une expansion des marges (marge EBITA ajustée du segment pour l'année à 27,6 %) et un flux de trésorerie disponible annuel de 3 245 millions de dollars.

Le conseil d'administration a approuvé une hausse du dividende trimestriel de 5 % à 0,555 $ par action (paiement le 10 décembre, ex-date le 14 novembre) et a autorisé des rachats d'au plus 50 millions d'actions, en plus des environ 20 millions d'actions restantes d'une autorisation précédente. Orientation 2026 : EPS ajusté 6,35–6,55, EPS GAAP 4,73–4,93, flux de trésorerie opérationnel 4,0–4,1 milliards, flux de trésorerie disponible 3,5–3,6 milliards, et programmes de rendement du capital d'environ 2,2 milliards (environ 1,0 milliard de rachats, environ 1,2 milliard de dividendes).

Emerson (NYSE: EMR) hat die Ergebnisse des vierten Quartals (Q4) und des Geschäftsjahres 2025 für den Zeitraum bis zum 30. September 2025 gemeldet und eine erste Prognose für 2026 gegeben. Q4-Nettoverkäufe betrugen 4.855 Mio. USD, ein Anstieg von 5 % gegenüber dem Vorjahr; Jahresumsatz betrug 18.016 Mio. USD, ein Anstieg von 3 % gegenüber dem Vorjahr. GAAP EPS betrug im Q4 1,12 USD und 4,03 USD für das Geschäftsjahr 2025; angepasstes EPS betrug 1,62 im Q4 und 6,00 für das Geschäftsjahr 2025. Emerson meldete Margenexpansion (FY angepasstes Segment-EBITA-Marge 27,6 %) und einen freien Cashflow des Geschäftsjahres von 3.245 Mio. USD.

Der Vorstand hat eine Erhöhung der vierteljährlichen Dividende um 5 % auf 0,555 USD pro Aktie genehmigt (Zahlung am 10. Dezember, Ex-Tag 14. November) und den Rückkauf von bis zu 50 Mio. Aktien genehmigt, zusätzlich zu ca. 20 Mio. Aktien, die noch aus einer früheren Genehmigung verbleiben. Ausblick 2026: angepasstes EPS 6,35–6,55, GAAP EPS 4,73–4,93, operativer Cashflow 4,0–4,1 Mrd. USD, freier Cashflow 3,5–3,6 Mrd. USD, und geplante Kapitalrückflüsse von ca. 2,2 Mrd. USD (~1,0 Mrd. USD Reaukauf, ~1,2 Mrd. USD Dividenden).

إمرسون (بورصة نيويورك: EMR) أصدرت نتائج الربع الرابع للسنة المالية 2025 والسنة المالية كاملة حتى 30 سبتمبر 2025، وقدمت توجيهات أولية لعام 2026. صافي المبيعات للربع الرابع بلغ 4,855 مليون دولار، بارتفاع 5% على أساس سنوي؛ مبيعات السنة المالية بلغت 18,016 مليون دولار، بارتفاع 3% على أساس سنوي. EPS GAAP كان 1.12 دولار في الربع الرابع و4.03 دولار للسنة المالية 2025؛ EPS المعدل كان 1.62 في الربع الرابع و6.00 للسنة المالية 2025. ذكرت إمرسون توسع الهامش (الهامش المعدل لـ EBITA للقطاعات للسنة عند 27.6%) وتدفق نقدي حر للسنة قدره 3,245 مليون دولار.

وافقت المجلس على زيادة توزيعات الأرباح الربعية بنسبة 5% إلى 0.555 دولار للسهم (الدفع 10 ديسمبر، التسجيل 14 نوفمبر) وسمحت بإعادة شراء أسهم حتى 50 مليون سهم، بالإضافة إلى نحو 20 مليون سهم متبقية من تفويض سابق. التوجيه لعام 2026: EPS المعدل 6.35–6.55، EPS GAAP 4.73–4.93، التدفق النقدي التشغيلي 4.0–4.1 مليار دولار، التدفق النقدي الحر 3.5–3.6 مليار دولار، وخطط عودة النقد بقيمة نحو 2.2 مليار دولار (حوالي 1.0 مليار إعادة شراء أسهم، حوالي 1.2 مليار دولار توزيعات).

Positive
  • FY adjusted segment EBITA margin expanded to 27.6%
  • GAAP EPS FY 2025 increased to $4.03 (+43% YoY)
  • Adjusted EPS FY 2025 of $6.00 (+9% YoY)
  • FY free cash flow of $3,245 million (+12% YoY)
  • Board-authorized buyback of up to 50 million shares plus ~20 million remaining
  • Quarterly dividend increased 5% to $0.555 per share
Negative
  • None.

Insights

Emerson shows margin expansion, higher EPS and stronger cash returns with a bigger buyback and dividend hike ahead of fiscal 2026.

Emerson reported year-over-year improvements: net sales rose to $18,016 from $17,492, GAAP EPS increased to $4.03 from $2.82, adjusted EPS rose to $6.00 from $5.49, and full-year margin expanded to 16.3% from 11.5%. Management also announced a 5% quarterly dividend increase to $0.555 per share and Board authorization to repurchase up to 50 million shares, noted as an addition to a prior 60 million-share program with ~20 million shares remaining.

Cash generation remains central: fiscal 2025 operating cash flow was $3,676 million and free cash flow was $3,245 million, and guidance for fiscal 2026 targets operating cash flow of $4.0B$4.1B and free cash flow of $3.5B$3.6B. The company plans to return roughly $2.2B in 2026 via ~$1.0B in repurchases and ~$1.2B in dividends, and it projects adjusted EPS of $6.35$6.55 for fiscal 2026.

Key dependencies and risks are explicit in the disclosure: achievement of the $6.35$6.55 adjusted EPS range, delivery of the stated $4.0B$4.1B operating cash flow, and execution of the announced share repurchases and dividend plan during fiscal 2026. Watch quarterly results and cash-flow conversion against guidance, and monitor any updates to the outstanding share-repurchase capacity tied to the previously authorized 60 million-share program when management reports progress.

ST. LOUIS, Nov. 5, 2025 /PRNewswire/ -- Emerson (NYSE: EMR) today reported results1 for its fourth quarter and fiscal year ended September 30, 2025. Emerson also declared a 5% quarterly cash dividend increase to $0.555 per share of common stock payable December 10, 2025 to stockholders of record November 14, 2025. Additionally, Emerson announced that its Board of Directors authorized the company to repurchase up to 50 million shares of its common stock. This is in addition to the authorization approved in March 2020, to repurchase 60 million shares of common stock, which has approximately 20 million shares remaining.

(dollars in millions, except per share)


2024 Q4

2025 Q4

Change


2024

2025

Change

Underlying Orders2




6 %




4 %

Net Sales


$4,619

$4,855

5 %


$17,492

$18,016

3 %

Underlying Sales3




4 %




3 %

Pretax Earnings


$679

$796



$2,020

$2,934


Margin


14.7 %

16.4 %

170 bps


11.5 %

16.3 %

480 bps

Adjusted Segment EBITA4


$1,210

$1,333



$4,552

$4,975


Margin


26.2 %

27.5 %

130 bps


26.0 %

27.6 %

160 bps

GAAP Earnings Per Share


$0.97

$1.12

15 %


$2.82

$4.03

43 %

Adjusted Earnings Per Share5


$1.48

$1.62

9 %


$5.49

$6.00

9 %

Operating Cash Flow


$1,073

$1,011

(6) %


$3,317

$3,676

11 %

Free Cash Flow


$905

$843

(7) %


$2,898

$3,245

12 %

Management Commentary

"Emerson delivered a solid fiscal 2025, marked by continued margin expansion, robust cash generation and strong execution. The dedication of our global teams was instrumental in driving our performance and advancing Emerson's position as the leading automation company," said Emerson President and Chief Executive Officer Lal Karsanbhai. "We are proud of the meaningful progress we have made integrating AspenTech and of completing the Test & Measurement integration – delivering on our commitment to achieve $200M of run-rate cost synergies."

Karsanbhai continued, "Our portfolio is aligned with long-term secular trends positioned to drive sustainable growth into the future. These trends have driven mid-single-digit underlying orders growth for three consecutive quarters, supporting our sales expectations for 2026 and beyond. We remain confident in our operational execution and ability to return cash to shareholders, accelerating further value creation."

2026 Outlook

The following tables summarize the fiscal year 2026 guidance framework. As we pivot capital allocation to returning cash to shareholders, the 2026 outlook assumes returning ~$2.2B through ~$1B of share repurchases and ~$1.2B of dividends.


2026 Q1

2026

Net Sales Growth

~4%

~5.5%

Underlying Sales Growth

~2%

~4%

Earnings Per Share

~$0.98

$4.73 - $4.93

Amortization of intangibles

~$0.35

~$1.42

Restructuring and related costs

~$0.05

~$0.15

Acquisition/divestiture fees and related costs

~$0.02

~$0.05

Adjusted Earnings Per Share

~$1.40

$6.35 - $6.55

Operating Cash Flow


$4.0B - $4.1B

Free Cash Flow


$3.5B - $3.6B

Share Repurchase


~$1.0B


Results are presented on a continuing operations basis.

2 Underlying orders do not include AspenTech.

3 Underlying sales exclude the impact of currency translation, and significant acquisitions and divestitures.

4 Adjusted segment EBITA represents segment earnings less restructuring and intangibles amortization expense.

5 Adjusted EPS excludes intangibles amortization expense, restructuring and related costs, acquisition/divestiture gains, losses, fees and related costs, and discrete taxes.

Conference Call

Today, beginning at 7:30 a.m. Central Time / 8:30 a.m. Eastern Time, Emerson management will discuss the fourth quarter and fiscal year 2025 results during an investor conference call. Participants can access a live webcast available at https://ir.emerson.com at the time of the call.  A replay of the call will be available for 90 days. Conference call slides will be posted in advance of the call on the company website.

Upcoming Event

Emerson will hold an in-person and virtual investor conference on Thursday, Nov. 20 in New York City. A live webcast of the investor conference will begin at 8:00 a.m. Central Time / 9:00 a.m. Eastern Time. A link to register and attend the webcast is available at https://ir.emerson.com/. The webcast will remain available for 90 days.

About Emerson

Emerson (NYSE: EMR) is a global industrial technology leader that provides advanced automation. With an unmatched portfolio of intelligent devices, controls systems, and industrial software, Emerson delivers solutions that automate and optimize business performance. Headquartered in Saint Louis, Missouri, Emerson combines innovative technology with proven operational excellence to power the future of automation. For more information, visit Emerson.com.

Forward-Looking and Cautionary Statements

Statements in this press release that are not strictly historical may be "forward-looking" statements, which represent management's expectations, based on currently available information. Actual results, performance or achievements could differ materially from those expressed in any forward-looking statement. Any forward-looking statements in this press release speak only as of the date of this press release. Emerson undertakes no obligation to update any such statements to reflect new information or later developments. Examples of risks and uncertainties that may cause our actual results or performance to be materially different from those expressed or implied by forward looking statements include the scope, duration and ultimate impacts of the Russia-Ukraine and other global conflicts, as well as economic and currency conditions, market demand, pricing, protection of intellectual property, cybersecurity, tariffs, competitive and technological factors, inflation, among others, as set forth in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the SEC. The outlook contained herein represents the Company's expectation for its consolidated results, other than as noted herein.

Emerson uses our Investor Relations website, https://ir.emerson.com, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts and social media. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

Contacts






Investors:

Media:


Colleen Mettler

Joseph Sala / Greg Klassen / Connor Murphy


(314) 553-2197

Joele Frank, Wilkinson Brimmer Katcher



(212) 355-4449


(tables attached)








Table 1

EMERSON AND SUBSIDIARIES

CONSOLIDATED OPERATING RESULTS

(AMOUNTS IN MILLIONS EXCEPT PER SHARE, UNAUDITED)










Quarter Ended
September 30,


Year Ended
September 30,




2024


2025


2024


2025









Net sales

$       4,619


$       4,855


$    17,492


$    18,016

Costs and expenses:








     Cost of sales

2,248


2,335


8,607


8,497

     SG&A expenses

1,315


1,330


5,142


5,103

     Gain on subordinated interest



(79)


     Loss on Copeland note receivable



279


     Other deductions, net

359


302


1,434


1,245

     Interest expense, net

18


92


175


237

     Interest income from related party1



(86)


Earnings from continuing operations before income taxes

679


796


2,020


2,934

Income taxes

149


160


415


696

Earnings from continuing operations

530


636


1,605


2,238

Discontinued operations, net of tax

438


1


350


8

Net earnings

968


637


1,955


2,246

Less: Noncontrolling interests in subsidiaries

(28)



(13)


(47)

Net earnings common stockholders

$         996


$         637


$      1,968


$      2,293









Earnings common stockholders








Earnings from continuing operations

$         558


$         636


$      1,618


$      2,285

Discontinued operations

438


1


350


8

Net earnings common stockholders

$         996


$         637


$      1,968


$      2,293









Diluted avg. shares outstanding

573.9


565.5


574.0


566.7









Diluted earnings per share common stockholders








Earnings from continuing operations

$        0.97


$        1.12


$        2.82


$        4.03

Discontinued operations

0.76



0.61


0.01

Diluted earnings per common share

$        1.73


$        1.12


$        3.43


$        4.04


















Quarter Ended
September 30,


Year Ended
September 30,




2024


2025


2024


2025

Other deductions, net








     Amortization of intangibles

$         266


$         208


$      1,077


$         884

     Restructuring costs

58


66


228


136

     Other

35


28


129


225

          Total

$         359


$         302


$      1,434


$      1,245


1 Represents interest on the Copeland note receivable.

 




Table 2

EMERSON AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(DOLLARS IN MILLIONS, UNAUDITED)






Year Ended Sept 30,


2024


2025

Assets




     Cash and equivalents

$           3,588


$           1,544

     Receivables, net

2,927


3,101

     Inventories

2,180


2,213

     Other current assets

1,497


1,725

          Total current assets

10,192


8,583

     Property, plant & equipment, net

2,807


2,871

     Goodwill

18,067


18,193

     Other intangible assets

10,436


9,458

     Other

2,744


2,859

          Total assets

$         44,246


$         41,964





Liabilities and equity




     Short-term borrowings and current




        maturities of long-term debt

$              532


$           4,797

     Accounts payable

1,335


1,384

     Accrued expenses

3,875


3,616

          Total current liabilities

5,742


9,797

     Long-term debt

7,155


8,319

     Other liabilities

3,840


3,550

Equity




     Common stockholders' equity

21,636


20,282

     Noncontrolling interests in subsidiaries

5,873


16

     Total equity

27,509


20,298

          Total liabilities and equity

$         44,246


$         41,964

 





Table 3


EMERSON AND SUBSIDIARIES


CONSOLIDATED STATEMENTS OF CASH FLOWS


(DOLLARS IN MILLIONS, UNAUDITED)









Year Ended Sept 30,




2024


2025


Operating activities






Net earnings


$            1,955


$           2,246


Earnings from discontinued operations, net of tax


(350)


(8)


Adjustments to reconcile net earnings to net cash provided by operating activities:






        Depreciation and amortization


1,689


1,518


        Stock compensation


260


263


        Amortization of acquisition-related inventory step-up


231



        Pension expense (income)


(79)


(12)


        Pension funding


(38)


(46)


        Changes in operating working capital


(151)


(9)


        Gain on subordinated interest


(79)



        Loss on Copeland note receivable


279



        Other, net


(400)


(276)


            Cash from continuing operations


3,317


3,676


            Cash from discontinued operations


15


(578)


            Cash provided by operating activities


3,332


3,098








Investing activities






Capital expenditures


(419)


(431)


Purchases of businesses, net of cash and equivalents acquired


(8,342)


(37)


Proceeds from subordinated interest


79



Other, net


(114)


(125)


    Cash from continuing operations


(8,796)


(593)


    Cash from discontinued operations


3,436



    Cash used in investing activities


(5,360)


(593)








Financing activities






Net increase (decrease) in short-term borrowings


(15)


1,110


Proceeds from short-term borrowings greater than three months


322


8,008


Payments of short-term borrowings greater than three months


(327)


(4,918)


Proceeds from long-term debt



1,544


Payments of long-term debt


(547)


(503)


Dividends paid


(1,201)


(1,192)


Purchases of common stock


(435)


(1,167)


AspenTech purchases of common stock


(208)



Purchase of noncontrolling interest



(7,244)


Repurchase of AspenTech share awards



(76)


Other, net


(44)


(72)


    Cash used in financing activities


(2,455)


(4,510)








Effect of exchange rate changes on cash and equivalents


20


(39)


Decrease in cash and equivalents


(4,463)


(2,044)


Beginning cash and equivalents


8,051


3,588


Ending cash and equivalents


$            3,588


$           1,544


 

Table 4

EMERSON AND SUBSIDIARIES

SEGMENT SALES AND EARNINGS

(AMOUNTS IN MILLIONS, UNAUDITED)


The following tables show results for the Company's segments on an adjusted segment EBITA basis and are intended to
supplement the Company's results of operations, including its segment earnings which are defined as earnings before
interest and taxes. The Company defines adjusted segment and total segment EBITA as segment earnings excluding
intangibles amortization expense, and restructuring and related expense. Adjusted segment and total segment EBITA,
and adjusted segment and total segment EBITA margin are measures used by management and may be useful for
investors to evaluate the Company's segments' operational performance.



Quarter Ended Sept 30,



2024


2025


Reported


Underlying











Sales









Final Control

$           1,167


$           1,215


4 %


3 %


Measurement & Analytical

1,119


1,152


3 %


2 %


Discrete Automation

643


676


5 %


4 %


Safety & Productivity

352


360


2 %


1 %


Intelligent Devices

$           3,281


$           3,403


4 %


3 %











Control Systems & Software

995


1,067


7 %


6 %


Test & Measurement

360


408


13 %


12 %


Software and Control

$           1,355


$           1,475


9 %


8 %











Eliminations

(17)


(23)






Total

$           4,619


$           4,855


5 %


4 %



Sales Growth by Geography



Quarter Ended
Sept 30,

Americas

6 %

Europe

3 %

Asia, Middle East & Africa

2 %


Table 4 cont.



Year Ended Sept 30,


2024


2025


Reported


Underlying









Sales








Final Control

$           4,204


$           4,380


4 %


4 %

Measurement & Analytical

4,061


4,143


2 %


2 %

Discrete Automation

2,506


2,521


1 %


1 %

Safety & Productivity

1,390


1,356


(2) %


(3) %

Intelligent Devices

$         12,161


$         12,400


2 %


2 %









Control Systems & Software

3,935


4,205


7 %


7 %

Test & Measurement

1,464


1,486


2 %


1 %

Software and Control

$           5,399


$           5,691


5 %


5 %









Eliminations

(68)


(75)





Total

$         17,492


$         18,016


3 %


3 %


Sales Growth by Geography



Year Ended
Sept 30,

Americas

5 %

Europe

(2) %

Asia, Middle East & Africa

3 %


Table 4 cont.



Quarter Ended Sept 30,


Quarter Ended Sept 30,


2024


2025


As
Reported
(GAAP)


Adjusted
EBITA
(Non-
GAAP)


As
Reported
(GAAP)


Adjusted
EBITA
(Non-
GAAP)

Earnings








Final Control

$          271


$          305


$          310


$          335

 Margins

23.2 %


26.1 %


25.6 %


27.6 %

Measurement & Analytical

295


326


317


348

 Margins

26.4 %


29.2 %


27.5 %


30.2 %

Discrete Automation

144


154


134


154

 Margins

22.3 %


23.9 %


19.9 %


22.9 %

Safety & Productivity

78


90


77


89

 Margins

22.2 %


25.4 %


21.0 %


24.3 %

Intelligent Devices

$          788


$          875


$          838


$          926

 Margins

24.0 %


26.6 %


24.6 %


27.2 %









Control Systems & Software

98


239


181


291

 Margins

9.8 %


24.0 %


17.0 %


27.3 %

Test & Measurement

(45)


96


(4)


116

 Margins

(12.4) %


26.7 %


(1.1) %


28.5 %

Software and Control

$            53


$          335


$          177


$          407

 Margins

3.9 %


24.7 %


12.0 %


27.6 %









Corporate items and interest expense, net:








Stock compensation

$           (57)


$           (52)


$           (65)


$           (55)

Unallocated pension and postretirement costs

37


37


27


27

Corporate and other

(124)


(60)


(89)


(34)

Interest (expense) income, net

(18)



(92)










Pretax Earnings / Adjusted EBITA

$          679


$       1,135


$          796


$       1,271

 Margins

14.7 %


24.6 %


16.4 %


26.2 %









Supplemental Total Segment Earnings:








Adjusted Total Segment EBITA



$       1,210




$       1,333

 Margins



26.2 %




27.5 %



Year Ended Sept 30,


Year Ended Sept 30,


2024


2025


As
Reported
(GAAP)


Adjusted
EBITA
(Non-
GAAP)


As
Reported
(GAAP)


Adjusted
EBITA (Non-
GAAP)

Earnings








Final Control

$          977


$       1,081


$       1,081


$       1,176

 Margins

23.2 %


25.7 %


24.7 %


26.9 %

Measurement & Analytical

1,056


1,137


1,112


1,182

 Margins

26.0 %


28.0 %


26.9 %


28.5 %

Discrete Automation

466


535


469


531

 Margins

18.6 %


21.3 %


18.6 %


21.0 %

Safety & Productivity

308


341


291


323

 Margins

22.2 %


24.5 %


21.5 %


23.8 %

Intelligent Devices

$       2,807


$       3,094


$       2,953


$       3,212

 Margins

23.1 %


25.4 %


23.8 %


25.9 %









Control Systems & Software

572


1,107


895


1,388

 Margins

14.5 %


28.1 %


21.3 %


33.0 %

Test & Measurement

(290)


351


(68)


375

Margins

(19.8) %


24.0 %


(4.5) %


25.3 %

Software and Control

$          282


$       1,458


$          827


$       1,763

 Margins

5.2 %


27.0 %


14.5 %


31.0 %









Corporate items and interest expense, net:








Stock compensation

(260)


(202)


(263)


(216)

Unallocated pension and postretirement costs

144


144


109


109

Corporate and other

(664)


(168)


(455)


(175)

Gain on subordinated interest

79




Loss on Copeland note receivable

(279)




Interest (expense) income, net

(175)



(237)


Interest income from related party1

86












Pretax Earnings / Adjusted EBITA

$       2,020


$       4,326


$       2,934


$       4,693

 Margins

11.5 %


24.7 %


16.3 %


26.0 %









Supplemental Total Segment Earnings:








Adjusted Total Segment EBITA



$       4,552




$       4,975

 Margins



26.0 %




27.6 %









1 Represents interest on the Copeland note receivable.


Table 4 cont.



Quarter Ended Sept 30,


Quarter Ended Sept 30,


2024


2025


Amortization of

Intangibles1


Restructuring

and

Related Costs2


Amortization of

Intangibles1


Restructuring

and

Related Costs2

Final Control

$                   22


$                   12


$                   22


$                     3

Measurement & Analytical

12


19


12


19

Discrete Automation

8


2


8


12

Safety & Productivity

7


5


7


5

Intelligent Devices

$                   49


$                   38


$                   49


$                   39









Control Systems & Software

126


15


101


9

Test & Measurement

141



107


13

Software and Control

$                 267


$                   15


$                 208


$                   22









Corporate


11



20

Total

$                 316


$                   64


$                 257


$                   81









1 Amortization of intangibles includes $49 and $49 reported in cost of sales for the three months ended September 30, 2024 and 2025, respectively.

2 Restructuring and related costs includes $6 and $15 of restructuring-related costs for the three months ended September 30, 2024 and 2025, respectively.



Year Ended Sept 30,


Year Ended Sept 30,


2024


2025


Amortization of

Intangibles1


Restructuring

and

Related Costs2


Amortization of

Intangibles1


Restructuring

and

Related Costs2

Final Control

$                   87


$                   17


$                   86


$                     9

Measurement & Analytical

55


26


45


25

Discrete Automation

34


35


32


30

Safety & Productivity

26


7


27


5

Intelligent Devices

$                 202


$                   85


$                 190


$                   69









Control Systems & Software

512


23


468


25

Test & Measurement

560


81


425


18

Software and Control

$              1,072


$                 104


$                 893


$                   43









Corporate


55



50

Total

$              1,274


$                 244


$              1,083


$                 162









1 Amortization of intangibles includes $196 and $199 reported in cost of sales for the twelve months ended September 30, 2024 and 2025, respectively.

2 Restructuring and related costs includes $16 and $26 of restructuring-related costs for the twelve months ended September 30, 2024 and 2025, respectively.



Quarter Ended Sept 30,


2024


2025





Depreciation and Amortization




Final Control

$                39


$                41

Measurement & Analytical

33


45

Discrete Automation

22


23

Safety & Productivity

15


15

Intelligent Devices

109


124





Control Systems & Software

150


123

Test & Measurement

153


120

Software and Control

303


243





     Corporate

14


12

          Total

$              426


$              379










Year Ended Sept 30,


2024


2025





Depreciation and Amortization




Final Control

$              159


$              161

Measurement & Analytical

138


140

Discrete Automation

87


87

Safety & Productivity

58


60

Intelligent Devices

442


448





Control Systems & Software

594


550

Test & Measurement

607


476

Software and Control

1,201


1,026





     Corporate

46


44

          Total

$           1,689


$           1,518

 

Table 5

EMERSON AND SUBSIDIARIES

ADJUSTED CORPORATE AND OTHER SUPPLEMENTAL

(AMOUNTS IN MILLIONS, UNAUDITED)


The following table shows the Company's stock compensation and corporate and other expenses on an adjusted basis.
The Company's definition of adjusted stock compensation excludes integration-related stock compensation expense. The
Company's definition of adjusted corporate and other excludes corporate restructuring and related costs, first year
purchase accounting related items and transaction fees, and certain gains, losses or impairments. These metrics are
useful for reconciling from total adjusted segment EBITA to the Company's consolidated adjusted EBITA.







Quarter Ended Sept 30,







2024


2025


Stock compensation (GAAP)





$                  (57)


$                  (65)


Integration-related stock compensation expense





5

1

10

3

Adjusted stock compensation (non-GAAP)





$                  (52)


$                  (55)









Quarter Ended Sept 30,







2024


2025


 Corporate and other (GAAP)





$                (124)


$                  (89)


 Corporate restructuring and related costs





9


16


 Acquisition/divestiture fees and related costs





46


39


 Loss on divestiture of business





9












 Adjusted corporate and other (Non-GAAP)





$                  (60)


$                  (34)









Year Ended Sept 30,







2024


2025


 Stock compensation (GAAP)





$                (260)


$                (263)


Integration-related stock compensation expense





58

2

47

4

 Adjusted stock compensation (non-GAAP)





$                (202)


$                (216)









Year Ended Sept 30,







2024


2025


 Corporate and other (GAAP)





$                (664)


$                (455)


 Corporate restructuring and related costs





12


25


 Loss on divestiture of businesses





48



 Acquisition/divestiture fees and related costs





205


255


 Amortization of acquisition-related inventory step-up





231












 Adjusted corporate and other (Non-GAAP)





$                (168)


$                (175)










1 Integration-related stock compensation expense relates to NI and includes $2 reported as restructuring costs

2 Integration-related stock compensation expense relates to NI and includes $43 reported as restructuring costs

3 Integration-related stock compensation expense relates to NI & AspenTech and includes $4 reported as restructuring costs

4 Integration-related stock compensation expense relates to NI & AspenTech and includes $25 reported as restructuring costs

 

Table 6

EMERSON AND SUBSIDIARIES

ADJUSTED EBITA & EPS SUPPLEMENTAL

(AMOUNTS IN MILLIONS EXCEPT PER SHARE, UNAUDITED)


The following tables, which show results on an adjusted EBITA basis and diluted earnings per share on an adjusted basis,
are intended to supplement the Company's discussion of its results of operations herein. The Company defines adjusted
EBITA as earnings excluding interest expense, net, income taxes, intangibles amortization expense, restructuring
expense, first year purchase accounting related items and transaction fees, and certain gains, losses or impairments.
Adjusted earnings per share excludes intangibles amortization expense, restructuring expense, first year purchase
accounting related items and transaction-related costs, and certain gains, losses or impairments. Adjusted EBITA,
adjusted EBITA margin, and adjusted earnings per share are measures used by management and may be useful for
investors to evaluate the Company's operational performance.



Quarter Ended Sept 30,


2024


2025





Pretax earnings

$             679


$             796

Percent of sales

14.7 %


16.4 %

Interest expense, net

18


92

Amortization of intangibles

316


257

Restructuring and related costs

64


81

Acquisition/divestiture fees and related costs

49


45

Loss on divestiture of business

9


Adjusted EBITA

$          1,135


$          1,271

Percent of sales

24.6 %


26.2 %






Quarter Ended Sept 30,


2024


2025





GAAP earnings from continuing operations per share

$            0.97


$            1.12





Amortization of intangibles

0.35


0.35

Restructuring and related costs

0.08


0.11

Acquisition/divestiture fees and related costs

0.06


0.06

Loss on divestiture of business

0.02


Discrete taxes


(0.02)





Adjusted earnings from continuing operations per share

$            1.48


$            1.62



Year Ended Sept 30,


2024


2025





Pretax earnings

$          2,020


$          2,934

Percent of sales

11.5 %


16.3 %

Interest expense, net

175


237

Interest income from related party1

(86)


Amortization of intangibles

1,274


1,083

Restructuring and related costs

244


162

Acquisition/divestiture fees and related costs

220


277

Amortization of acquisition-related inventory step-up

231


Loss on Copeland note receivable

279


Loss on divestiture of businesses

48


Gain on subordinated interest

(79)


Adjusted EBITA

$          4,326


$          4,693

Percent of sales

24.7 %


26.0 %






Year Ended Sept 30,


2024


2025





GAAP earnings from continuing operations per share

$            2.82


$            4.03





Amortization of intangibles

1.43


1.35

Restructuring and related costs

0.33


0.23

Acquisition/divestiture fees and related costs

0.26


0.33

Discrete taxes

(0.10)


0.06

Amortization of acquisition-related inventory step-up

0.38


Loss on Copeland note receivable

0.38


Loss on divestiture of businesses

0.09


Gain on subordinated interest

(0.10)






Adjusted earnings from continuing operations per share

$            5.49


$            6.00





1 Represents interest on the Copeland note receivable


Table 6 cont.

Quarter Ended September 30, 2025


Pretax
Earnings


Income
Taxes


Earnings
from
Cont.
Ops.


Non-
Controlling

Interests3


Net
Earnings
Common
Stockholders


Diluted
Earnings
Per
Share

As reported (GAAP)

$       796


$       160


$          636


$            —


$               636


$      1.12

Amortization of intangibles

257

1

59


198



198


0.35

Restructuring and related
costs

81

2

19


62



62


0.11

Acquisition/divestiture fees
and related costs

45


9


36



36


0.06

Discrete taxes


13


(13)



(13)


(0.02)

Adjusted (Non-GAAP)

$     1,179


$       260


$          919


$            —


$               919


$      1.62

Interest expense, net

$          92











Adjusted EBITA (Non-
GAAP)

$     1,271























1 Amortization of intangibles includes $49 reported in cost of sales.

2 Restructuring and related costs includes $15 of restructuring-related costs.

3 Non-Controlling Interests for AspenTech ceased as of March 12, 2025 with the completion of the buy-in.


Year Ended September 30, 2025


Pretax
Earnings


Income
Taxes


Earnings
from
Cont.
Ops.


Non-
Controlling

Interests3


Net
Earnings
Common
Stockholders


Diluted
Earnings
Per
Share

As reported (GAAP)

$     2,934


$       696


$       2,238


$           (47)


$            2,285


$      4.03

Amortization of intangibles

1,083

1

246


837


73


764


1.35

Restructuring and related
costs

162

2

29


133



133


0.23

Acquisition/divestiture fees
and related costs

277


43


234


48


186


0.33

Discrete taxes


(36)


36



36


0.06

Adjusted (Non-GAAP)

$     4,456


$       978


$       3,478


$            74


$            3,404


$      6.00

Interest expense, net

237











Adjusted EBITA (Non-
GAAP)

$     4,693























1 Amortization of intangibles includes $199 reported in cost of sales.

2 Restructuring and related costs includes $26 of restructuring-related costs.

3 Represents the non-controlling interest in AspenTech applied to AspenTech's share of each adjustment presented herein and eliminated from Emerson's consolidated results. Non-Controlling Interests for AspenTech ceased as of March 12, 2025 with the completion of the buy-in. 

 

Table 7

Reconciliations of Non-GAAP Financial Measures & Other


Reconciliations of Non-GAAP measures with the most directly comparable GAAP measure (dollars in millions,
except per share amounts). See tables 4 through 7 for additional non-GAAP reconciliations.


Q4 FY25 Underlying Sales Change

Reported

(Favorable) /
Unfavorable FX

(Acquisitions) /

Divestitures

Underlying

Final Control

4 %

(1) %

— %

3 %

Measurement & Analytical

3 %

(1) %

— %

2 %

Discrete Automation

5 %

(1) %

— %

4 %

Safety & Productivity

2 %

(1) %

— %

1 %

Intelligent Devices

4 %

(1) %

— %

3 %

Control Systems & Software

7 %

(1) %

— %

6 %

Test & Measurement

13 %

(1) %

— %

12 %

Software and Control

9 %

(1) %

— %

8 %

Emerson

5 %

(1) %

— %

4 %


Year Ended Sept 30, 2025 Underlying Sales Change

Reported

(Favorable) /
Unfavorable FX

(Acquisitions) /

Divestitures

Underlying

Final Control

4 %

— %

— %

4 %

Measurement & Analytical

2 %

— %

— %

2 %

Discrete Automation

1 %

— %

— %

1 %

Safety & Productivity

(2) %

(1) %

— %

(3) %

Intelligent Devices

2 %

— %

— %

2 %

Control Systems & Software

7 %

— %

— %

7 %

Test & Measurement

2 %

(1) %

— %

1 %

Software and Control

5 %

— %

— %

5 %

Emerson

3 %

— %

— %

3 %


Underlying Growth Guidance

2026 Q1

Guidance

2026

Guidance

Reported (GAAP)

~4%

~5.5%

(Favorable) / Unfavorable FX

~(2) pts

~(1.5) pts

(Acquisitions) / Divestitures

-

-

Underlying (non-GAAP)

~2%

~4%


2024 Q4 Adjusted Segment EBITA

EBIT

EBIT

Margin

Amortization

of

Intangibles

Restructuring
and Related
Costs

Adjusted
Segment
EBITA

Adjusted
Segment
EBITA
Margin

Final Control

$               271

23.2 %

$                 22

$                  12

$               305

26.1 %

Measurement & Analytical

295

26.4 %

12

19

326

29.2 %

Discrete Automation

144

22.3 %

8

2

154

23.9 %

Safety & Productivity

78

22.2 %

7

5

90

25.4 %

Intelligent Devices

$               788

24.0 %

$                 49

$                   38

$               875

26.6 %

Control Systems & Software

98

9.8 %

126

15

239

24.0 %

Test & Measurement

(45)

(12.4) %

141

96

26.7 %

Software and Control

$                 53

3.9 %

$               267

$                   15

$               335

24.7 %


2025 Q4 Adjusted Segment EBITA

EBIT

EBIT

Margin

Amortization
of
 Intangibles

Restructuring
and Related
Costs

Adjusted
Segment
EBITA

Adjusted
Segment
EBITA
Margin

Final Control

$               310

25.6 %

$                 22

$                     3

$               335

27.6 %

Measurement & Analytical

317

27.5 %

12

19

348

30.2 %

Discrete Automation

134

19.9 %

8

12

154

22.9 %

Safety & Productivity

77

21.0 %

7

5

89

24.3 %

Intelligent Devices

$               838

24.6 %

$                 49

$                   39

$               926

27.2 %

Control Systems & Software

181

17.0 %

101

9

291

27.3 %

Test & Measurement

(4)

(1.1) %

107

13

116

28.5 %

Software and Control

$               177

12.0 %

$               208

$                   22

$               407

27.6 %


Total Adjusted Segment EBITA


2024 Q4

2025 Q4

Pretax earnings (GAAP)


$                 679

$                 796

Margin


14.7 %

16.4 %

  Corporate items and interest expense, net


162

219

  Amortization of intangibles


316

257

  Restructuring and related costs


53

61

Adjusted segment EBITA (non-GAAP)


$              1,210

$              1,333

Margin


26.2 %

27.5 %


2024 Adjusted Segment EBITA

EBIT

EBIT

Margin

Amortization

of

Intangibles

Restructuring
and Related
Costs

Adjusted
Segment
EBITA

Adjusted
Segment
EBITA
Margin

Final Control

$               977

23.2 %

$                 87

$                  17

$           1,081

25.7 %

Measurement & Analytical

1,056

26.0 %

55

26

1,137

28.0 %

Discrete Automation

466

18.6 %

34

35

535

21.3 %

Safety & Productivity

308

22.2 %

26

7

341

24.5 %

Intelligent Devices

$           2,807

23.1 %

$               202

$                  85

$           3,094

25.4 %

Control Systems & Software

572

14.5 %

512

23

1,107

28.1 %

Test & Measurement

(290)

(19.8) %

560

81

351

24.0 %

Software and Control

$               282

5.2 %

$            1,072

$                104

$           1,458

27.0 %


2025 Adjusted Segment EBITA

EBIT

EBIT

Margin

Amortization
of
 Intangibles

Restructuring
and Related
Costs

Adjusted
Segment
EBITA

Adjusted
Segment
EBITA
Margin

Final Control

$           1,081

24.7 %

$                 86

$                    9

$           1,176

26.9 %

Measurement & Analytical

1,112

26.9 %

45

25

1,182

28.5 %

Discrete Automation

469

18.6 %

32

30

531

21.0 %

Safety & Productivity

291

21.5 %

27

5

323

23.8 %

Intelligent Devices

$           2,953

23.8 %

$               190

$                  69

$           3,212

25.9 %

Control Systems & Software

895

21.3 %

468

25

1,388

33.0 %

Test & Measurement

(68)

(4.5) %

425

18

375

25.3 %

Software and Control

$               827

14.5 %

$               893

$                  43

$           1,763

31.0 %


Total Adjusted Segment EBITA


2024

2025

Pretax earnings (GAAP)


$              2,020

$              2,934

Margin


11.5 %

16.3 %

  Corporate items and interest expense, net


1,069

846

  Amortization of intangibles


1,274

1,083

  Restructuring and related costs


189

112

Adjusted segment EBITA (non-GAAP)


$              4,552

$              4,975

Margin


26.0 %

27.6 %


Free Cash Flow


2024 Q4

2025 Q4




Operating cash flow (GAAP)


$              1,073

$              1,011




Capital expenditures


(168)

(168)




Free cash flow (non-GAAP)


$                 905

$                 843





Free Cash Flow


FY24

FY25


2026E

($ in billions)

Operating cash flow (GAAP)


$              3,317

$              3,676


 $4.0 - $4.1

Capital expenditures


(419)

(431)


~(0.45)

Free cash flow (non-GAAP)


$              2,898

$              3,245


$3.5 - $3.6


Note 1: Underlying sales and orders exclude the impact of currency translation and significant acquisitions and divestitures.

Note 2: All fiscal year 2026E figures are approximate, except where range is given.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/emerson-reports-fourth-quarter-and-full-year-2025-results-provides-initial-2026-outlook-302604806.html

SOURCE Emerson

FAQ

What did Emerson (EMR) report for net sales in fiscal Q4 2025?

Emerson reported $4,855 million in net sales for fiscal Q4 2025, up 5% year-over-year.

How much did Emerson (EMR) increase its quarterly dividend and when is it payable?

Emerson increased its quarterly dividend by 5% to $0.555 per share, payable on Dec. 10, 2025 to holders of record on Nov. 14, 2025.

How large is the new Emerson (EMR) share repurchase authorization announced Nov. 5, 2025?

The board authorized repurchases of up to 50 million shares, in addition to approximately 20 million shares remaining from a prior authorization.

What is Emerson's 2026 adjusted EPS guidance and free cash flow outlook?

Emerson guided Adjusted EPS $6.35–$6.55 for fiscal 2026 and free cash flow $3.5–$3.6 billion.

How much cash does Emerson (EMR) plan to return to shareholders in 2026?

Emerson plans to return roughly $2.2 billion in 2026, consisting of about $1.0 billion in share repurchases and $1.2 billion in dividends.

Where can investors access Emerson's Nov. 5, 2025 earnings call and replay?

The live webcast and a 90-day replay of the earnings call are available at https://ir.emerson.com.
Emerson Elec Co

NYSE:EMR

EMR Rankings

EMR Latest News

EMR Latest SEC Filings

EMR Stock Data

78.81B
561.32M
0.29%
83.87%
2.73%
Specialty Industrial Machinery
Electronic & Other Electrical Equipment (no Computer Equip)
Link
United States
ST LOUIS